Close Menu
Home » Twist Bioscience Revenues More Than Double in Q2 of FY 2019

Twist Bioscience Revenues More Than Double in Q2 of FY 2019

Apr 30, 2019
|
staff reporter

This article has been updated with additional information from Twist Bioscience's earnings call.

NEW YORK (GenomeWeb) – Twist Bioscience reported a 119 percent increase in second quarter fiscal year 2019 revenues after the close of market on Tuesday.

"We had another very strong quarter … driven by strong growth in both synbio and our genomics product line," said Emily Leproust, Twist's cofounder and CEO, during a conference call to discuss the financial results.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Gene Editing for the Gold

Gene editing could be an issue competitive sports need to address soon, four researchers from Arizona State University write at Slate.

Variant Linked to Heart Failure Risk

A genetic alteration appears to increase heart failure risk among people of African descent, according to the Washington Post.

A Different Future

In his look back at the past decade, BuzzFeed News' Peter Aldhous writes that direct-to-consumer genetic testing has led to "Facebook for genes."

Nature Examines Lifespans, Fast and Accurate Method for Long-Read Assembly, More

In Nature this week: genetic "clock" that can predict the lifespans of vertebrates, new assembler called wtdbg2, and more.

Dec
17
Featured Webinar

Non-Invasive Characterization of Solid Tumors via NGS Liquid Biopsy Testing

Sponsored by
Thermo Fisher Scientific

This webinar will review how liquid biopsy can be considered as an alternative and non-invasive method to tissue biopsy for cancer molecular characterization.

Dec
19
Featured Webinar

Evolution of Tumor Profiling in a Clinical Lab: Moving toward Comprehensive Genomic Profiling

Sponsored by
Qiagen

This webinar will provide a first-hand look at how a clinical lab evolved its tumor profiling workflow from a targeted panel approach toward comprehensive genomic profiling.  

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Sequencing

  1. Parkinson's Foundation Selects Five Sites for Genetic Testing, Counseling

  2. Abu Dhabi Teams Up With BGI, Oxford Nanopore for Population Sequencing Project

  3. At ASH, Researchers Discuss Rapid AML Nanopore Sequencing Assay for Analyzing Actionable Alterations

  4. Online Tool to Select Secondary Findings May Shorten Genetic Counseling Sessions

  5. Study Shows Feasibility of Circulating Trophoblast-Based Noninvasive Prenatal Testing

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.